Model
Edge
Quince Therapeutics Inc.
QNCX
Filing type
8-K
Filing date
Sep 13, 2026
Updated
Sep 14, 2026 ยท 2:42 PM
Copy reference
Filing
8-K
Completing Asset Acquisition or Sale, Changes in Board, Management or Compensation
Exhibits
EX-10.1
EX-10.1
EX-99.1
Completing Asset Acquisition or Sale, Changes in Board, Management or Compensation